Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Rodeghiero

Showing results (121-130 of 266) with videos related to

Pageof 27
Sort By:
Blut|April 1, 1989
Clinical effectiveness of desmopressin in a case of acquired von Willebrand's syndrome associated with benign monoclonal gammopathyG Castaman, F Rodeghiero, E Di Bona, et al.
Vox Sanguinis|January 1, 1992
Replacement therapy with virus-inactivated plasma concentrates in von Willebrand diseaseF Rodeghiero, G Castaman, D Meyer, et al.
Haematologica|November 1, 1993
Fibrinogen survival and fibrinopeptide A in acute leukemiaG Castaman, E Galloni, A V Dri, et al.
British Journal of Haematology|May 3, 2000
Autosomal dominant type 1 von willebrand disease due to G3639T mutation (C1130F) in exon 26 of von Willebrand factor gene: description of five Italian families and evidence for a founder effectG Castaman, J C Eikenboom, E Missiaglia, et al.
Lancet (London, England)|October 29, 1988
von Willebrand factor abnormalities in two patients with uraemiaF Rodeghiero, G Castaman, R Lombardi, et al.
Journal of Thrombosis and Haemostasis : JTH|June 22, 2010
Blood group significantly influences von Willebrand factor increase and half-life after desmopressin in von Willebrand disease VicenzaG Castaman, A Tosetto, J C Eikenboom, et al.
Haematologica|May 1, 1985
Successful treatment of neonatal "autoimmune" thrombocytopenia with high-dose intravenous immunoglobulinsG Castaman, F Rodeghiero, G F Ronconi, et al.
Thrombosis and Haemostasis|September 24, 1999
Inconsistency of association between type 1 von Willebrand disease phenotype and genotype in families identified in an epidemiological investigationG Castaman, J C Eikenboom, R M Bertina, et al.
Blood|November 1, 1996
The Ser460Pro substitution of the protein S (PS) gene in rare in Italian patients with type IIa PS deficiencyG Castaman, M Ruggeri, A Tosetto, et al.
Haematologica|November 1, 1993
The clinical significance of the antiplatelet antibody test based on results for 265 thrombocytopenic patientsA Tosetto, M Ruggeri, C Schiavotto, et al.
Pageof 27

Showing results (121-130 of 266) with videos related to

Sort By:
Pageof 27
Blut|April 1, 1989
Clinical effectiveness of desmopressin in a case of acquired von Willebrand's syndrome associated with benign monoclonal gammopathyG Castaman, F Rodeghiero, E Di Bona, et al.
Vox Sanguinis|January 1, 1992
Replacement therapy with virus-inactivated plasma concentrates in von Willebrand diseaseF Rodeghiero, G Castaman, D Meyer, et al.
Haematologica|November 1, 1993
Fibrinogen survival and fibrinopeptide A in acute leukemiaG Castaman, E Galloni, A V Dri, et al.
British Journal of Haematology|May 3, 2000
Autosomal dominant type 1 von willebrand disease due to G3639T mutation (C1130F) in exon 26 of von Willebrand factor gene: description of five Italian families and evidence for a founder effectG Castaman, J C Eikenboom, E Missiaglia, et al.
Lancet (London, England)|October 29, 1988
von Willebrand factor abnormalities in two patients with uraemiaF Rodeghiero, G Castaman, R Lombardi, et al.
Journal of Thrombosis and Haemostasis : JTH|June 22, 2010
Blood group significantly influences von Willebrand factor increase and half-life after desmopressin in von Willebrand disease VicenzaG Castaman, A Tosetto, J C Eikenboom, et al.
Haematologica|May 1, 1985
Successful treatment of neonatal "autoimmune" thrombocytopenia with high-dose intravenous immunoglobulinsG Castaman, F Rodeghiero, G F Ronconi, et al.
Thrombosis and Haemostasis|September 24, 1999
Inconsistency of association between type 1 von Willebrand disease phenotype and genotype in families identified in an epidemiological investigationG Castaman, J C Eikenboom, R M Bertina, et al.
Blood|November 1, 1996
The Ser460Pro substitution of the protein S (PS) gene in rare in Italian patients with type IIa PS deficiencyG Castaman, M Ruggeri, A Tosetto, et al.
Haematologica|November 1, 1993
The clinical significance of the antiplatelet antibody test based on results for 265 thrombocytopenic patientsA Tosetto, M Ruggeri, C Schiavotto, et al.
Pageof 27